Medtronic cardiovascular "procedural packages"
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
2027MD
NAICS
339113 - Surgical Appliance and Supplies Manufacturing
Classification Code
-
Additional Details
The Defense Logistics Agency (DLA) Troop Support, a key procurement office within the Department of Defense, has issued a Sources Sought notice seeking information from potential suppliers capable of providing Medtronic cardiovascular "procedural packages." This request for information (RFI) is intended to identify qualified sources and gather market intelligence for future procurement planning; it does not constitute a solicitation or a commitment to award a contract.
The primary objective of this procurement is to ensure the availability of comprehensive cardiovascular procedural packages for use in military Medical Treatment Facilities (MTFs). Each procedural package comprises FDA-approved Medtronic cardiovascular products and all necessary ancillary accessories, such as entry needles and guidewires, tailored to the specific needs of individual patients undergoing cardiovascular surgery. The product mix within each package may vary, reflecting the unique clinical requirements of each case.
A critical requirement of this initiative is the flexibility and responsiveness of delivery. The DLA is considering three delivery models to best support MTFs:
- **Just-In-Time (JIT) Delivery:** The manufacturer’s field representative delivers the required products directly to the MTF immediately prior to surgery, bringing a range of sizes and types of implants and auxiliary products, as well as instrumentation sets, to accommodate intraoperative decisions.
- **Direct Vendor Delivery (DVD):** Orders are placed through the ECAT system, with products shipped directly to the customer via standard transportation carriers.
- **Consignment:** Products are consigned to the MTF, ensuring immediate on-site availability as needed.
In addition to product delivery, the manufacturer must provide robust technical support. This includes having a qualified representative available on-site at the MTF within a timeframe specified by the facility, to offer technical advice and guidance to physicians before, during, and after implantation procedures. Furthermore, technical support must be accessible 24 hours a day, seven days a week, to address any emergent needs or questions.
All products supplied under this requirement must be approved by the U.S. Food and Drug Administration (FDA), ensuring compliance with stringent safety and efficacy standards.
This notice is classified under NAICS code 339113 (Surgical Appliance and Supplies Manufacturing), and there are no set-aside restrictions; all qualified vendors are encouraged to respond. The anticipated place of performance is Philadelphia, Pennsylvania.
Interested parties are invited to submit their responses electronically in PDF format to the primary point of contact, Kathleen M. Adamow Wandall, at [email protected]. The deadline for responses is November 20, 2026.
This RFI represents an opportunity for manufacturers and suppliers with the requisite capabilities, FDA-approved product lines, and robust field support infrastructure to inform the DLA’s future acquisition strategy for critical cardiovascular surgical supplies.
For further details and to monitor updates, interested vendors should refer to the official notice on SAM.gov at: https://sam.gov/opp/19b65d9bfdfc4903a5dd3bea6079a4eb/view.